Does Wegovy Affect Birth Control Pills — and What Should You Do About It?

Wegovy slows gastric emptying, which can reduce absorption of oral medicines taken at the same time, including the contraceptive pill.
NHS guidance specifically flags oral contraceptive pill users as a group who should discuss contraception management with a clinician before starting semaglutide.
The absorption concern is most pronounced during the dose-escalation phase, when the gastric-slowing effect tends to be strongest.
Switching to a non-oral contraceptive (such as a patch, implant or injection) while on Wegovy removes the absorption uncertainty entirely.

Wegovy (semaglutide) can potentially reduce how well oral contraceptive pills are absorbed, particularly during the early weeks of treatment when the medicine is slowing digestion most noticeably. This is a genuine clinical consideration, not a theoretical one — your prescriber needs to know you take oral contraception before starting. Wegovy is a prescription-only medicine, so a clinician assesses your full picture before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The practical decisions oral contraceptive pill users need to make before and during Wegovy treatment

Why Wegovy and the pill interact in the first place

Semaglutide works partly by slowing how quickly food and other substances leave the stomach, a process called delayed gastric emptying. That's useful for appetite control, but it also means oral medicines can sit in the stomach longer before being absorbed into the bloodstream. For most tablets this matters little. For the contraceptive pill, which depends on consistent and predictable absorption to maintain its protective effect, the picture is less clear-cut.

The concern isn't that semaglutide chemically interferes with the pill's hormones. It's that slower gut transit may reduce or delay how much of the pill's active ingredient reaches your bloodstream. If you want a thorough grounding in how Wegovy can affect the pill and what that means for your contraceptive cover, we cover the question in full detail on a dedicated page. You can read the NHS England guidance on weight-management injections, which addresses this directly, on the NHS England medicines for obesity page.

The effect is also likely dose-dependent. At 0.25mg (the starting dose) gastric slowing is modest; as doses increase through the titration schedule, the effect tends to intensify. That trajectory matters when you're thinking about your contraceptive risk window.

What the clinical guidance actually says, and the tirzepatide distinction worth knowing

NHS guidance recommends that women using oral contraceptives discuss their contraception with a clinician before starting Wegovy. The practical suggestion is to consider switching to a non-oral method, such as a contraceptive patch, implant, injection or coil, for the duration of treatment. These routes bypass the gut entirely, so gastric emptying is irrelevant to how reliably they work.

If switching isn't possible or desirable, adding a barrier method (condoms) during the escalation phase is a reasonable interim step, discussed with your prescriber. The NHS semaglutide medicines page includes guidance on what to tell your doctor before starting.

One distinction worth knowing: for the Wegovy tablet (oral semaglutide, approved by the MHRA in June 2026), the interaction question takes a slightly different shape, since the medicine itself is taken orally and the timing rules around it (empty stomach, no other medicines for 30 minutes) already affect how you'd take an oral contraceptive on the same morning. That's a separate conversation, covered in more detail on our Wegovy and the pill page.

The tirzepatide comparison is also worth a brief mention. For Mounjaro (tirzepatide), NHS guidance is more specific: oral contraceptive users should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase. There is no equivalent explicit instruction for semaglutide, but the underlying mechanism (gastric slowing) is shared, which is why the general caution still applies.

What this means for your decision to start Wegovy

The absorption question shouldn't put you off treatment. It's a manageable consideration, not a barrier. The decision tree is relatively straightforward: tell your prescriber you take the pill, discuss which contraceptive switch or addition suits you, and proceed with that plan in place. Most women find a workable solution quickly, many had already been thinking about a longer-acting contraceptive method anyway.

Worth doing before your consultation: check the name of your contraceptive pill and whether it's combined (oestrogen and progestogen) or progestogen-only. That information takes about 30 seconds to find on the packet and gives your prescriber something concrete to work with immediately.

For context on what the treatment itself involves, including eligibility and how the dose schedule works, the Wegovy treatment overview is a good starting point. Our weight-loss treatment page also covers the full range of licensed options if you're still deciding. If you'd like to see how the clinical team approaches these questions, our clinical lead's profile gives you a sense of the oversight behind every prescription.

Questions to raise at your consultation

A consultation is the right place to work through the specifics. Bring the name of your current pill, how long you've been taking it, and any other medicines you take regularly. Your prescriber will review everything before any prescription is issued, that review is where the contraception conversation happens, not as an afterthought.

If Wegovy sounds right for you and you'd like to understand the cost alongside the clinical picture, the Wegovy pill pricing page sets out what private treatment involves. For background on how and when the Wegovy tablet received UK approval, the approval history page has the detail. Further general FAQs are on the faqs page.

Once you're ready, checking your eligibility takes a few minutes and puts your case in front of a GPhC-registered prescriber the same day, a real clinician, reading your answers, not a form-sorting algorithm.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions